RPC(SZ:000650) Sou Hu Cai Jing·2025-08-01 12:22Group 1 - The core viewpoint of the news is that Renhe Pharmaceutical (000650) has shown a slight increase in stock price, with a closing price of 5.94 yuan, up by 1.02% as of August 1, 2025 [1] - The company reported a total operating revenue of 986 million yuan for the first quarter of 2025, a year-on-year decrease of 20.36%, while the net profit attributable to shareholders was 164 million yuan, down by 7.33% [1] - The company's liquidity ratios are strong, with a current ratio of 8.246 and a quick ratio of 7.594, indicating good short-term financial health [1] Group 2 - Renhe Pharmaceutical has made investments in 38 companies and participated in 2,295 bidding projects, showcasing its active engagement in the market [2] - The company holds 63 trademark registrations and 3 patents, reflecting its focus on intellectual property [2] - Renhe Pharmaceutical has obtained 6 administrative licenses, indicating compliance with regulatory requirements [2]